Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Acucela helps develop Otsuka's rebamipide for dry eye

Executive Summary

Acucela (oral small molecules for blinding diseases) and Otsuka Pharmaceutical have teamed up to co-develop the latter's Phase III rebamipide for dry eye, marking Otsuka's third ophthalmic-focused deal this year.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register